Dual-tracer PET/CT helps pick patients for liver transplant

January 22, 2013

Dual-tracer PET/CT is more effective than contrast-enhanced CT for hepatocellular carcinoma (HCC) staging and may warrant "serious consideration" for use in determining which patients could benefit the most from a liver transplant, according to a study published online January 15 in the Journal of Nuclear Medicine.